Stay updated on Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial
Sign up to get notified when there's something new on the Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial page.

Latest updates to the Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial page
- CheckyesterdayChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, indicating a new release of the study page. This change does not alter the trial data, eligibility criteria, or other substantive content.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page’s display version/revision indicator was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check29 days agoChange DetectedRevision tag updated from v3.5.0 to v3.5.2 on the page.SummaryDifference0.0%

- Check58 days agoChange DetectedA new frontend revision v3.5.0 is implemented, replacing the previous revision v3.4.3.SummaryDifference0.0%

- Check65 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check94 days agoChange DetectedThe page shows a new revision number (v3.4.2) replacing the previous (v3.4.1). This appears to be a software maintenance update with no visible changes to the study details or functionality.SummaryDifference0.0%

Stay in the know with updates to Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial page.